Antiphospholipid syndrome (APS) & catastrophic APS (CAPS)
Thrombosis / autoimmune · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Management
- Suspect APS with unprovoked or recurrent thrombosis (arterial OR venous), thrombosis at a young age or an unusual site, or recurrent pregnancy loss — confirmed by a persistently positive lupus anticoagulant, anticardiolipin or anti-β2-glycoprotein-I antibody
- Recognise CATASTROPHIC APS (CAPS): multi-organ small-vessel thrombosis developing over days — renal, pulmonary, cerebral, cardiac, skin — with thrombocytopenia and a high mortality. Look for a trigger (infection, surgery, anticoagulation withdrawal, malignancy)
- Anticoagulate: therapeutic heparin for acute thrombosis/CAPS; long-term thrombotic APS is treated with WARFARIN (target INR 2–3, or higher/arterial per specialist) — avoid DOACs, especially in triple-positive or arterial disease
- CAPS: the “triple therapy” — therapeutic anticoagulation + high-dose corticosteroid + plasma exchange and/or IVIG, plus treat the trigger; rituximab/eculizumab in refractory cases
- Treat the organ complications (stroke, PE, renal failure, adrenal haemorrhage) and give VTE prophylaxis where anticoagulation is not yet therapeutic
- Involve haematology/rheumatology; in pregnancy, aspirin + LMWH under specialist care
Drugs & doses
Therapeutic heparin / LMWH (acute)
Warfarin (long-term thrombotic APS — not DOAC)
High-dose corticosteroid (CAPS)
Plasma exchange / IVIG (CAPS)
Rituximab / eculizumab (refractory CAPS)
Disposition
Admit for any acute thrombosis; CAPS is an ICU-level emergency. Haematology + rheumatology.
A prolonged APTT that does NOT correct on mixing is the lupus anticoagulant — paradoxically a clotting (not bleeding) risk. Do not stop anticoagulation abruptly in APS: withdrawal can trigger CAPS.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.